DR. DAN C. TRIGG — History
CCN 321302 | 3-year financial timeline | COVID resilience: 46/100
🛡️ Public data only — no PHI permitted on this instance.
$16M
Latest Revenue (FY2022)
+4.8%
Revenue CAGR (3yr)
-10.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $14M | $15M | $16M | +5.6% | +4.8% |
| Operating Expenses | $15M | $16M | $18M | +12.3% | +7.7% |
| Operating Margin | -5.0% | -4.2% | -10.8% | -159.1% | +0.0% |
| Net Income | $-1M | $-1M | $-2M | -173.6% | +0.0% |
| Licensed Beds | 25 | 25 | 25 | +0.0% | +0.0% |
| Total Patient Days | 739 | 452 | 373 | -17.5% | -29.0% |
| Medicare Day % | 53% | 67% | 40% | -39.4% | -12.8% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 46/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +9.9% ($14M → $16M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+4.8%
This Hospital
+7.6%
State Avg
Latest Margin
-10.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $17M | -13.7% |
| FY2024 (proj) | $17M | -16.6% |
| FY2025 (proj) | $18M | -19.4% |